Project Grant R34HL174877
Award Date
8/15/24
Completion Date
7/31/27
Dollars Obligated
$265K
Federal Agency
National Heart Lung and Blood Institute
Federal Grant Program
93.837
Assistance Type
Project Grant
Place of Performance
Minneapolis, MN 55455, USA
Similar Awards
This federal Project Grant award, valued at $142,804, was provided by the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research (CFDA 93.837) program. The grant supports research to identify predictors of treatment response to pharmacologic and non-pharmacologic interventions for Cough Hypersensitivity Syndrome (CHS), a disorder characterized by chronic coughing that can lead to serious health issues. Specifically, the award aims to (1) investigate...
The National Heart, Lung, and Blood Institute (NHLBI) awarded a $269,922 Project Grant under the Cardiovascular Diseases Research program (CFDA 93.837) to Steth X Microsystems Inc. to develop a smart, wearable contact microphone patch for extended and remote monitoring of lung functions. The goal is to create a low-profile, battery-powered wireless device capable of accurately detecting and quantifying adventitious lung sounds as well as breathing abnormalities in patients with respiratory...
This $608,826 Project Grant awarded by the National Institute on Deafness and Other Communication Disorders (NIDCD) under the Research Related to Deafness and Communication Disorders program (CFDA 93.173) will develop a new class of wireless, skin-conformable, and dual-sensing wearable system to monitor voice and upper airway (VUA) health. The key products and services to be delivered include: A single neck-worn wearable device that uses neck surface accelerometry and surface electromyography to...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health (NIH), under the Cardiovascular Diseases Research program (CFDA 93.837), provides $807,067 to the University of Virginia to conduct research on novel respiratory kinematic physiomarkers for predicting severe respiratory failure. The project aims to quantify and elucidate the diagnostic and prognostic significance of respiratory motion patterns, with the goal of improving...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), supports the development of an innovative mobile health system for remote monitoring of patients with chronic obstructive pulmonary disease (COPD). The $1,052,276 award to Lasarrus Clinic And Research Center Inc. will fund a longitudinal study to validate a wearable, multimodal sensor device called "WearMe" that can continuously...
The National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research (CFDA 93.837) program, awarded a $310,948 Project Grant to Minnesota Healthsolutions Corporation, a for-profit woman-owned small business, on September 15, 2023. The grant funds the development of an adaptable platform to support patients with behavior change interventions aimed at improving adherence to treatment and prevention for multiple chronic diseases. The platform will utilize remote...
This federal Project Grant award, with an ID of R01DC022510, was provided by the National Institute on Deafness and Other Communication Disorders (NIDCD) under the Research Related to Deafness and Communication Disorders program (CFDA 93.173). The $633,694 award, with a completion date of November 30, 2029, is focused on developing a non-invasive therapy using a vocal fold lamina propria extract (VFLPX) to promote wound healing and address vocal fold scarring and laryngotracheal injuries,...
The National Heart, Lung, and Blood Institute (NHLBI) awarded a $725,088 Project Grant (CFDA 93.837 - Cardiovascular Diseases Research) to Rush University Medical Center to conduct a hybrid type 1 effectiveness-implementation study on optimizing the effectiveness and implementation of COPD self-management treatment. The study aims to determine the optimal combination of self-management education, physical activity, and inhaler training components that produce the best outcomes on...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), provides $387,116 to the University of South Florida to research the sensory neuronal mechanisms underlying the development of house dust mite-induced airway hyperreactivity, a key characteristic of asthma. The 5-year award, effective May 1, 2025, aims to identify the specific nerve subtypes and signaling pathways activated by house dust mite...
This federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), provides $477,290 to Mayo Clinic to investigate the underlying behavioral mechanisms that impact a home-based pulmonary rehabilitation program for patients with chronic obstructive pulmonary disease (COPD). The research aims to determine the associations between patterns of physical activity, sedentary behavior, sleep, and cognitive...